Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Cell Death & Disease|June 8, 2026
PRAS40-driven pro-inflammatory macrophage polarization is required for inflammatory bowel diseaseChengfei Zhang, Yufei Bo, Jia Deng, et al.Oncogenesis|December 27, 2025
PRAS40 promotes colorectal cancer stemness by enhancing glycolysis through triggering PGK1 acetylationChengfei Zhang, Yufei Bo, Ting Zhang, et al.Cell|July 24, 2024
Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypesYu Yang, Xueyan Chen, Jieying Pan, et al.Cellular & Molecular Immunology|August 20, 2025
SARDH in the 1-C metabolism sculpts the T-cell fate and serves as a potential cancer therapeutic targetWen Si, Sijin Cheng, Haiyin He, et al.Cell|August 22, 2023
A pan-cancer single-cell panorama of human natural killer cellsFei Tang, Jinhu Li, Lu Qi, et al.Cellular & Molecular Biology Letters|September 28, 2024
mTOR/miR-142-3p/PRAS40 signaling cascade is critical for tuberous sclerosis complex-associated renal cystogenesisShuyun Zhao, Shuai Hao, Jiasheng Zhou, et al.Cancer Cell|September 20, 2024
Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulationYang Gao, Jianan Li, Wenfeng Cheng, et al.Cancer Cell|July 9, 2024
Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancerYuqing Chen, Dongfang Wang, Yingjie Li, et al.Cell Reports|September 11, 2025
Integrated spatial transcriptomic profiling to dissect the cellular characteristics of tumor-associated tertiary lymphoid structuresXiangjie Li, Xiaojing Chu, Wenbin Xu, et al.Cancer Research|January 27, 2026
Targeting LRRC15 in Cancer-Associated Fibroblasts Modifies the Extracellular Matrix and Enhances Tumor Immune Responses to Suppress Lung Cancer ProgressionLu Qi, Guohui Dang, Xinnan Ling, et al.Pageof 2